Global Somatostatin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 107

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Somatostatin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Somatostatin size is estimated to be XX million in 2021 from USD 310.8 million in 2020, with a change of XX% between 2020 and 2021. The global Somatostatin market size is expected to grow at a CAGR of 10.9% for the next five years.

Market segmentation
Somatostatin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    0.25mg/pcs
    0.75mg/pcs
    3mg/pcs

Market segment by Application can be divided into
    Hormonal Disorder
    Oncology
    Metabolic Disorder
    Others

The key market players for global Somatostatin market are listed below:
    Merck (Schweiz) AG
    SANOFI-AVENTIS FRANCE
    Lyomark Pharma GmbH
    ALFA WASSERMANN S.p.A.
    Polypeptide Laboratories, Inc
    SAMARTH
    UBPL
    HYBIO
    TianTaiShan
    Yangtze River
    Siyao
    Shuangcheng
    Hainan Zhonghe
    SL PHARM
    Wuhan Hualong
    Qingdao Guoda
    Chengdu Shengnuo
    Longjin

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Somatostatin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin from 2019 to 2021.
Chapter 3, the Somatostatin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Somatostatin Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Somatostatin Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 0.25mg/pcs
        1.2.3 0.75mg/pcs
        1.2.4 3mg/pcs
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Somatostatin Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hormonal Disorder
        1.3.3 Oncology
        1.3.4 Metabolic Disorder
        1.3.5 Others
    1.4 Global Somatostatin Market Size & Forecast
        1.4.1 Global Somatostatin Sales in Value (2016-2026))
        1.4.2 Global Somatostatin Sales in Volume (2016-2026)
        1.4.3 Global Somatostatin Price by Type (2016-2026) & (USD/Pcs)
    1.5 Global Somatostatin Production Capacity Analysis
        1.5.1 Global Somatostatin Total Production Capacity (2016-2026)
        1.5.2 Global Somatostatin Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Somatostatin Market Drivers
        1.6.2 Somatostatin Market Restraints
        1.6.3 Somatostatin Trends Analysis

2 Manufacturers Profiles
    2.1 Merck (Schweiz) AG
        2.1.1 Merck (Schweiz) AG Details
        2.1.2 Merck (Schweiz) AG Major Business
        2.1.3 Merck (Schweiz) AG Somatostatin Product and Services
        2.1.4 Merck (Schweiz) AG Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 SANOFI-AVENTIS FRANCE
        2.2.1 SANOFI-AVENTIS FRANCE Details
        2.2.2 SANOFI-AVENTIS FRANCE Major Business
        2.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Services
        2.2.4 SANOFI-AVENTIS FRANCE Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Lyomark Pharma GmbH
        2.3.1 Lyomark Pharma GmbH Details
        2.3.2 Lyomark Pharma GmbH Major Business
        2.3.3 Lyomark Pharma GmbH Somatostatin Product and Services
        2.3.4 Lyomark Pharma GmbH Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 ALFA WASSERMANN S.p.A.
        2.4.1 ALFA WASSERMANN S.p.A. Details
        2.4.2 ALFA WASSERMANN S.p.A. Major Business
        2.4.3 ALFA WASSERMANN S.p.A. Somatostatin Product and Services
        2.4.4 ALFA WASSERMANN S.p.A. Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Polypeptide Laboratories, Inc
        2.5.1 Polypeptide Laboratories, Inc Details
        2.5.2 Polypeptide Laboratories, Inc Major Business
        2.5.3 Polypeptide Laboratories, Inc Somatostatin Product and Services
        2.5.4 Polypeptide Laboratories, Inc Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 SAMARTH
        2.6.1 SAMARTH Details
        2.6.2 SAMARTH Major Business
        2.6.3 SAMARTH Somatostatin Product and Services
        2.6.4 SAMARTH Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 UBPL
        2.7.1 UBPL Details
        2.7.2 UBPL Major Business
        2.7.3 UBPL Somatostatin Product and Services
        2.7.4 UBPL Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 HYBIO
        2.8.1 HYBIO Details
        2.8.2 HYBIO Major Business
        2.8.3 HYBIO Somatostatin Product and Services
        2.8.4 HYBIO Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 TianTaiShan
        2.9.1 TianTaiShan Details
        2.9.2 TianTaiShan Major Business
        2.9.3 TianTaiShan Somatostatin Product and Services
        2.9.4 TianTaiShan Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Yangtze River
        2.10.1 Yangtze River Details
        2.10.2 Yangtze River Major Business
        2.10.3 Yangtze River Somatostatin Product and Services
        2.10.4 Yangtze River Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Siyao
        2.11.1 Siyao Details
        2.11.2 Siyao Major Business
        2.11.3 Siyao Somatostatin Product and Services
        2.11.4 Siyao Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Shuangcheng
        2.12.1 Shuangcheng Details
        2.12.2 Shuangcheng Major Business
        2.12.3 Shuangcheng Somatostatin Product and Services
        2.12.4 Shuangcheng Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Hainan Zhonghe
        2.13.1 Hainan Zhonghe Details
        2.13.2 Hainan Zhonghe Major Business
        2.13.3 Hainan Zhonghe Somatostatin Product and Services
        2.13.4 Hainan Zhonghe Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 SL PHARM
        2.14.1 SL PHARM Details
        2.14.2 SL PHARM Major Business
        2.14.3 SL PHARM Somatostatin Product and Services
        2.14.4 SL PHARM Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.15 Wuhan Hualong
        2.15.1 Wuhan Hualong Details
        2.15.2 Wuhan Hualong Major Business
        2.15.3 Wuhan Hualong Somatostatin Product and Services
        2.15.4 Wuhan Hualong Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.16 Qingdao Guoda
        2.16.1 Qingdao Guoda Details
        2.16.2 Qingdao Guoda Major Business
        2.16.3 Qingdao Guoda Somatostatin Product and Services
        2.16.4 Qingdao Guoda Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.17 Chengdu Shengnuo
        2.17.1 Chengdu Shengnuo Details
        2.17.2 Chengdu Shengnuo Major Business
        2.17.3 Chengdu Shengnuo Somatostatin Product and Services
        2.17.4 Chengdu Shengnuo Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.18 Longjin
        2.18.1 Longjin Details
        2.18.2 Longjin Major Business
        2.18.3 Longjin Somatostatin Product and Services
        2.18.4 Longjin Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Somatostatin Sales by Manufacturer
    3.1 Global Somatostatin Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Somatostatin Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Somatostatin
    3.4 Market Concentration Rate
        3.4.1 Top 3 Somatostatin Manufacturer Market Share
        3.4.2 Top 6 Somatostatin Manufacturer Market Share
    3.5 Global Somatostatin Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Somatostatin Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Somatostatin Market Size by Region
        4.1.1 Global Somatostatin Sales in Volume by Region (2016-2026)
        4.1.2 Global Somatostatin Revenue by Region (2016-2026)
    4.2 North America Somatostatin Revenue (2016-2026)
    4.3 Europe Somatostatin Revenue (2016-2026)
    4.4 Asia-Pacific Somatostatin Revenue (2016-2026)
    4.5 South America Somatostatin Revenue (2016-2026)
    4.6 Middle East and Africa Somatostatin Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Somatostatin Sales in Volume by Type (2016-2026)
    5.2 Global Somatostatin Revenue by Type (2016-2026)
    5.3 Global Somatostatin Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Somatostatin Sales in Volume by Application (2016-2026)
    6.2 Global Somatostatin Revenue by Application (2016-2026)
    6.3 Global Somatostatin Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Somatostatin Sales by Type (2016-2026)
    7.2 North America Somatostatin Sales by Application (2016-2026)
    7.3 North America Somatostatin Market Size by Country
        7.3.1 North America Somatostatin Sales in Volume by Country (2016-2026)
        7.3.2 North America Somatostatin Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Somatostatin Sales by Type (2016-2026)
    8.2 Europe Somatostatin Sales by Application (2016-2026)
    8.3 Europe Somatostatin Market Size by Country
        8.3.1 Europe Somatostatin Sales in Volume by Country (2016-2026)
        8.3.2 Europe Somatostatin Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Somatostatin Sales by Type (2016-2026)
    9.2 Asia-Pacific Somatostatin Sales by Application (2016-2026)
    9.3 Asia-Pacific Somatostatin Market Size by Region
        9.3.1 Asia-Pacific Somatostatin Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Somatostatin Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Somatostatin Sales by Type (2016-2026)
    10.2 South America Somatostatin Sales by Application (2016-2026)
    10.3 South America Somatostatin Market Size by Country
        10.3.1 South America Somatostatin Sales in Volume by Country (2016-2026)
        10.3.2 South America Somatostatin Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Somatostatin Sales by Type (2016-2026)
    11.2 Middle East & Africa Somatostatin Sales by Application (2016-2026)
    11.3 Middle East & Africa Somatostatin Market Size by Country
        11.3.1 Middle East & Africa Somatostatin Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Somatostatin Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Somatostatin Typical Distributors
    12.3 Somatostatin Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Somatostatin Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Somatostatin Revenue by Application, (USD Million), 2021-2026
    Table 3. Merck (Schweiz) AG Basic Information, Manufacturing Base and Competitors
    Table 4. Merck (Schweiz) AG Major Business
    Table 5. Merck (Schweiz) AG Somatostatin Product and Services
    Table 6. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. SANOFI-AVENTIS FRANCE Basic Information, Manufacturing Base and Competitors
    Table 8. SANOFI-AVENTIS FRANCE Major Business
    Table 9. SANOFI-AVENTIS FRANCE Somatostatin Product and Services
    Table 10. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Lyomark Pharma GmbH Basic Information, Manufacturing Base and Competitors
    Table 12. Lyomark Pharma GmbH Major Business
    Table 13. Lyomark Pharma GmbH Somatostatin Product and Services
    Table 14. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. ALFA WASSERMANN S.p.A. Basic Information, Manufacturing Base and Competitors
    Table 16. ALFA WASSERMANN S.p.A. Major Business
    Table 17. ALFA WASSERMANN S.p.A. Somatostatin Product and Services
    Table 18. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Polypeptide Laboratories, Inc Basic Information, Manufacturing Base and Competitors
    Table 20. Polypeptide Laboratories, Inc Major Business
    Table 21. Polypeptide Laboratories, Inc Somatostatin Product and Services
    Table 22. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. SAMARTH Basic Information, Manufacturing Base and Competitors
    Table 24. SAMARTH Major Business
    Table 25. SAMARTH Somatostatin Product and Services
    Table 26. SAMARTH Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. UBPL Basic Information, Manufacturing Base and Competitors
    Table 28. UBPL Major Business
    Table 29. UBPL Somatostatin Product and Services
    Table 30. UBPL Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. HYBIO Basic Information, Manufacturing Base and Competitors
    Table 32. HYBIO Major Business
    Table 33. HYBIO Somatostatin Product and Services
    Table 34. HYBIO Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. TianTaiShan Basic Information, Manufacturing Base and Competitors
    Table 36. TianTaiShan Major Business
    Table 37. TianTaiShan Somatostatin Product and Services
    Table 38. TianTaiShan Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Yangtze River Basic Information, Manufacturing Base and Competitors
    Table 40. Yangtze River Major Business
    Table 41. Yangtze River Somatostatin Product and Services
    Table 42. Yangtze River Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Siyao Basic Information, Manufacturing Base and Competitors
    Table 44. Siyao Major Business
    Table 45. Siyao Somatostatin Product and Services
    Table 46. Siyao Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Shuangcheng Basic Information, Manufacturing Base and Competitors
    Table 48. Shuangcheng Major Business
    Table 49. Shuangcheng Somatostatin Product and Services
    Table 50. Shuangcheng Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Hainan Zhonghe Basic Information, Manufacturing Base and Competitors
    Table 52. Hainan Zhonghe Major Business
    Table 53. Hainan Zhonghe Somatostatin Product and Services
    Table 54. Hainan Zhonghe Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 55. SL PHARM Basic Information, Manufacturing Base and Competitors
    Table 56. SL PHARM Major Business
    Table 57. SL PHARM Somatostatin Product and Services
    Table 58. SL PHARM Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 59. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
    Table 60. Wuhan Hualong Major Business
    Table 61. Wuhan Hualong Somatostatin Product and Services
    Table 62. Wuhan Hualong Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 63. Qingdao Guoda Basic Information, Manufacturing Base and Competitors
    Table 64. Qingdao Guoda Major Business
    Table 65. Qingdao Guoda Somatostatin Product and Services
    Table 66. Qingdao Guoda Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 67. Chengdu Shengnuo Basic Information, Manufacturing Base and Competitors
    Table 68. Chengdu Shengnuo Major Business
    Table 69. Chengdu Shengnuo Somatostatin Product and Services
    Table 70. Chengdu Shengnuo Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 71. Longjin Basic Information, Manufacturing Base and Competitors
    Table 72. Longjin Major Business
    Table 73. Longjin Somatostatin Product and Services
    Table 74. Longjin Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 75. Global Somatostatin Sales by Manufacturer (2019-2021e) & (K Pcs)
    Table 76. Global Somatostatin Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 77. Market Position of Manufacturers in Somatostatin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 78. Global Somatostatin Production Capacity by Company, (K Pcs): 2020 VS 2021
    Table 79. Head Office and Somatostatin Production Site of Key Manufacturer
    Table 80. Somatostatin New Entrant and Capacity Expansion Plans
    Table 81. Somatostatin Mergers & Acquisitions in the Past Five Years
    Table 82. Global Somatostatin Sales by Region (2016-2021e) & (K Pcs)
    Table 83. Global Somatostatin Sales by Region (2021-2026) & (K Pcs)
    Table 84. Global Somatostatin Revenue by Region (2016-2021e) & (USD Million)
    Table 85. Global Somatostatin Revenue by Region (2021-2026) & (USD Million)
    Table 86. Global Somatostatin Sales by Type (2016-2021e) & (K Pcs)
    Table 87. Global Somatostatin Sales by Type (2021-2026) & (K Pcs)
    Table 88. Global Somatostatin Revenue by Type (2016-2021e) & (USD Million)
    Table 89. Global Somatostatin Revenue by Type (2021-2026) & (USD Million)
    Table 90. Global Somatostatin Price by Type (2016-2021e) & (USD/Pcs)
    Table 91. Global Somatostatin Price by Type (2021-2026) & (USD/Pcs)
    Table 92. Global Somatostatin Sales by Application (2016-2021e) & (K Pcs)
    Table 93. Global Somatostatin Sales by Application (2021-2026) & (K Pcs)
    Table 94. Global Somatostatin Revenue by Application (2016-2021e) & (USD Million)
    Table 95. Global Somatostatin Revenue by Application (2021-2026) & (USD Million)
    Table 96. Global Somatostatin Price by Application (2016-2021e) & (USD/Pcs)
    Table 97. Global Somatostatin Price by Application (2021-2026) & (USD/Pcs)
    Table 98. North America Somatostatin Sales by Country (2016-2021e) & (K Pcs)
    Table 99. North America Somatostatin Sales by Country (2021-2026) & (K Pcs)
    Table 100. North America Somatostatin Revenue by Country (2016-2021e) & (USD Million)
    Table 101. North America Somatostatin Revenue by Country (2021-2026) & (USD Million)
    Table 102. North America Somatostatin Sales by Type (2016-2021e) & (K Pcs)
    Table 103. North America Somatostatin Sales by Type (2021-2026) & (K Pcs)
    Table 104. North America Somatostatin Sales by Application (2016-2021e) & (K Pcs)
    Table 105. North America Somatostatin Sales by Application (2021-2026) & (K Pcs)
    Table 106. Europe Somatostatin Sales by Country (2016-2021e) & (K Pcs)
    Table 107. Europe Somatostatin Sales by Country (2021-2026) & (K Pcs)
    Table 108. Europe Somatostatin Revenue by Country (2016-2021e) & (USD Million)
    Table 109. Europe Somatostatin Revenue by Country (2021-2026) & (USD Million)
    Table 110. Europe Somatostatin Sales by Type (2016-2021e) & (K Pcs)
    Table 111. Europe Somatostatin Sales by Type (2021-2026) & (K Pcs)
    Table 112. Europe Somatostatin Sales by Application (2016-2021e) & (K Pcs)
    Table 113. Europe Somatostatin Sales by Application (2021-2026) & (K Pcs)
    Table 114. Asia-Pacific Somatostatin Sales by Region (2016-2021e) & (K Pcs)
    Table 115. Asia-Pacific Somatostatin Sales by Region (2021-2026) & (K Pcs)
    Table 116. Asia-Pacific Somatostatin Revenue by Region (2016-2021e) & (USD Million)
    Table 117. Asia-Pacific Somatostatin Revenue by Region (2021-2026) & (USD Million)
    Table 118. Asia-Pacific Somatostatin Sales by Type (2016-2021e) & (K Pcs)
    Table 119. Asia-Pacific Somatostatin Sales by Type (2021-2026) & (K Pcs)
    Table 120. Asia-Pacific Somatostatin Sales by Application (2016-2021e) & (K Pcs)
    Table 121. Asia-Pacific Somatostatin Sales by Application (2021-2026) & (K Pcs)
    Table 122. South America Somatostatin Sales by Country (2016-2021e) & (K Pcs)
    Table 123. South America Somatostatin Sales by Country (2021-2026) & (K Pcs)
    Table 124. South America Somatostatin Revenue by Country (2016-2021e) & (USD Million)
    Table 125. South America Somatostatin Revenue by Country (2021-2026) & (USD Million)
    Table 126. South America Somatostatin Sales by Type (2016-2021e) & (K Pcs)
    Table 127. South America Somatostatin Sales by Type (2021-2026) & (K Pcs)
    Table 128. South America Somatostatin Sales by Application (2016-2021e) & (K Pcs)
    Table 129. South America Somatostatin Sales by Application (2021-2026) & (K Pcs)
    Table 130. Middle East & Africa Somatostatin Sales by Country (2016-2021e) & (K Pcs)
    Table 131. Middle East & Africa Somatostatin Sales by Country (2021-2026) & (K Pcs)
    Table 132. Middle East & Africa Somatostatin Revenue by Country (2016-2021e) & (USD Million)
    Table 133. Middle East & Africa Somatostatin Revenue by Country (2021-2026) & (USD Million)
    Table 134. Middle East & Africa Somatostatin Sales by Type (2016-2021e) & (K Pcs)
    Table 135. Middle East & Africa Somatostatin Sales by Type (2021-2026) & (K Pcs)
    Table 136. Middle East & Africa Somatostatin Sales by Application (2016-2021e) & (K Pcs)
    Table 137. Middle East & Africa Somatostatin Sales by Application (2021-2026) & (K Pcs)
    Table 138. Direct Channel Pros & Cons
    Table 139. Indirect Channel Pros & Cons
    Table 140. Somatostatin Typical Distributors
    Table 141. Somatostatin Typical Customers
List of Figures
    Figure 1. Somatostatin Picture
    Figure 2. Global Somatostatin Sales Market Share by Type in 2020
    Figure 3. 0.25mg/pcs
    Figure 4. 0.75mg/pcs
    Figure 5. 3mg/pcs
    Figure 6. Global Somatostatin Sales Market Share by Application in 2020
    Figure 7. Hormonal Disorder
    Figure 8. Oncology
    Figure 9. Metabolic Disorder
    Figure 10. Others
    Figure 11. Global Somatostatin Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
    Figure 12. Global Somatostatin Market Size and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Somatostatin Sales (2016-2026) & (K Pcs)
    Figure 14. Global Somatostatin Price by Type (2016-2026) & (USD/Pcs)
    Figure 15. Global Somatostatin Production Capacity (2016-2026) & (K Pcs)
    Figure 16. Global Somatostatin Production Capacity by Geographic Region: 2020 VS 2021
    Figure 17. Somatostatin Market Drivers
    Figure 18. Somatostatin Market Restraints
    Figure 19. Somatostatin Market Trends
    Figure 20. Global Somatostatin Sales Market Share by Manufacturer in 2020
    Figure 21. Global Somatostatin Revenue Market Share by Manufacturer in 2020
    Figure 22. Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 23. Top 3 Somatostatin Manufacturer (Revenue) Market Share in 2020
    Figure 24. Top 6 Somatostatin Manufacturer (Revenue) Market Share in 2020
    Figure 25. Global Somatostatin Sales Market Share by Region (2016-2026)
    Figure 26. Global Somatostatin Revenue Market Share by Region (2016-2026)
    Figure 27. North America Somatostatin Revenue (2016-2026) & (USD Million)
    Figure 28. Europe Somatostatin Revenue (2016-2026) & (USD Million)
    Figure 29. Asia-Pacific Somatostatin Revenue (2016-2026) & (USD Million)
    Figure 30. South America Somatostatin Revenue (2016-2026) & (USD Million)
    Figure 31. Middle East & Africa Somatostatin Revenue (2016-2026) & (USD Million)
    Figure 32. Global Somatostatin Sales Market Share by Type (2016-2026)
    Figure 33. Global Somatostatin Revenue Market Share by Type (2016-2026)
    Figure 34. Global Somatostatin Price by Type (2016-2026) & (USD/Pcs)
    Figure 35. Global Somatostatin Sales Market Share by Application (2016-2026)
    Figure 36. Global Somatostatin Revenue Market Share by Application (2016-2026)
    Figure 37. Global Somatostatin Price by Application (2016-2026) & (USD/Pcs)
    Figure 38. North America Somatostatin Sales Market Share by Type (2016-2026)
    Figure 39. North America Somatostatin Sales Market Share by Application (2016-2026)
    Figure 40. North America Somatostatin Sales Market Share by Country (2016-2026)
    Figure 41. North America Somatostatin Revenue Market Share by Country (2016-2026)
    Figure 42. United States Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Canada Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Mexico Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Europe Somatostatin Sales Market Share by Type (2016-2026)
    Figure 46. Europe Somatostatin Sales Market Share by Application (2016-2026)
    Figure 47. Europe Somatostatin Sales Market Share by Country (2016-2026)
    Figure 48. Europe Somatostatin Revenue Market Share by Country (2016-2026)
    Figure 49. Germany Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. France Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. United Kingdom Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Russia Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Italy Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Asia-Pacific Somatostatin Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Somatostatin Sales Market Share by Application (2016-2026)
    Figure 56. Asia-Pacific Somatostatin Sales Market Share by Region (2016-2026)
    Figure 57. Asia-Pacific Somatostatin Revenue Market Share by Region (2016-2026)
    Figure 58. China Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Korea Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America Somatostatin Sales Market Share by Type (2016-2026)
    Figure 65. South America Somatostatin Sales Market Share by Application (2016-2026)
    Figure 66. South America Somatostatin Sales Market Share by Country (2016-2026)
    Figure 67. South America Somatostatin Revenue Market Share by Country (2016-2026)
    Figure 68. Brazil Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Argentina Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Middle East & Africa Somatostatin Sales Market Share by Type (2016-2026)
    Figure 71. Middle East & Africa Somatostatin Sales Market Share by Application (2016-2026)
    Figure 72. Middle East & Africa Somatostatin Sales Market Share by Country (2016-2026)
    Figure 73. Middle East & Africa Somatostatin Revenue Market Share by Country (2016-2026)
    Figure 74. Turkey Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Egypt Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Saudi Arabia Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. South Africa Somatostatin Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Sales Channel: Direct Channel vs Indirect Channel
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin

Related Reports

Global Somatostatin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Somatostatin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Somatostatin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Somatostatin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Somatostatin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Global Somatostatin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Somatostatin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Somatostatin market size was valued at USD 346.3 million in 2023 and is forecast to a readjusted size of USD 715 million by 2030 with a CAGR of 10.9% during review period.

Global Somatostatin Supply, Demand and Key Producers, 2024-2030

Global Somatostatin Supply, Demand and Key Producers, 2024-2030

date 20 Feb 2024

date Pharma & Healthcare

The global Somatostatin market size is expected to reach $ 715 million by 2030, rising at a market growth of 10.9% CAGR during the forecast period (2024-2030).

Product Tags

somatostatin somatostatin analogs

Somatostatin and Somatostatin Analogs

somatostatin

somatostatin drugs

somatostatin analogs

somatostatin receptor 4

somatostatin receptor 2

somatostatin acetate

somatostatin analogue drug

somatostatin for injection

somatostatin for injection production demand producers

Somatostatin Receptor Type 4

Somatostatin Receptor Type 2

Somatostatin API

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>